Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
BENEFIX (AUTHORIZED: HEMOPHILIA B)
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
||
|
WHO-ATC |
B02BD09
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
||
|
FDA ORPHAN DRUG |
82294
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
||
|
FDA ORPHAN DRUG |
377412
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
||
|
WHO-VATC |
QB02BD09
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
||
|
NDF-RT |
N0000184169
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
181054-95-5
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
GENERIC (FAMILY) | |||
|
CHEMBL2109205
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
5163
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
382L14738L
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
C82270
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
DB00100
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
7607
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
382L14738L
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
P00740
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
SUB03451MIG
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
100000089406
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
1300488
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
HH-12
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | |||
|
N0000175979
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | Increased Coagulation Activity [PE] | ||
|
N0000007914
Created by
admin on Mon Mar 31 18:30:06 GMT 2025 , Edited by admin on Mon Mar 31 18:30:06 GMT 2025
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] |
ACTIVE MOIETY